Transactions

Peterson McVicar acts for Leede Jones Gable Inc. in a proposed Private Placement with Acasti Pharma Inc.

On February 1, 2017 Leede Jones Gable Inc. entered into a finder’s agreement with Acasti Pharma Inc. (“Acasti”) in connection with a proposed private placement of $2 million aggregate principal amount of unsecured convertible debentures and warrants to acquire Class A shares of Acasti, with arm’s length investors (collectively, the “Private Placement”).

In part, the Private Placement is intended to provide a comprehensive financing package to fund Acasti’s operations until December 31, 2017, through the completion of the manufacturing scale-up and planning for the Phase 3 clinical trial for the continued development of CaPre®.

Leede Jones Gable is one of Canada’s leading independent investment dealers, providing a full range of investment products and services to clients all across Canada.

Back

Recent Transactions

31 December 2021

Peterson McVicar Acts for Bitfarms in $100 Million Credit Facility

Learn More

08 December 2021

Peterson McVicar Acts for Red Cloud in Upsize of Fission 3.0 Brokered Private Placement to up to C$7.5 Million

Learn More

11 November 2021

Peterson McVicar acts for Bitfarms as it Acquires 24 Megawatts of Hydro Power in the U.S. and Enters into Memorandum of Understanding to Expand Up to 99 MW

Learn More

09 November 2021

Peterson McVicar Acts for HIVE Blockchain in $110,020,000 Bought Deal Private Placement Financing

Learn More